Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
November 2004
2004:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010
News | News in brief | News Features
News
Science searches shift up a gear as Google starts Scholar engine
Google has unveiled a test version of a search engine aimed specifically at academic material, the Google Scholar.
Nature (25 November 2004)
| Full Text |
Lean budget leaves scientists wanting more
The federal budget, passed by Congress on 20 November, provides little new money for research and imposes cuts on several agencies.
Nature (25 November 2004)
| Full Text |
NIH head stands firm over plans for open access
The director of the US National Institutes of Health (NIH) has hit back at critics of his proposal for a freely accessible literature archive.
Nature (25 November 2004)
| Full Text |
Report censures political screening of advisory boards
Asking scientists questions about their political affiliations before allowing them to serve on government panels is "inappropriate", according to a US National Academies report.
Nature (25 November 2004)
| Full Text |
Junior scientists are denied access to data, says survey
A study, which is the first attempt to estimate the extent to which trainee scientists suffer from data-withholding, found that a quarter of them have had requests for data denied.
Nature (25 November 2004)
| Full Text |
Summit calls for clear view of deposits in all biobanks
Researchers agreed at a meeting last week that action must be taken to coordinate human-tissue banks if these resources are to be exploited to the full.
Nature (25 November 2004)
| Full Text |
Campaign to fight malaria hit by surge in demand for medicine
An alarming shortfall of a key drug is undermining an international drive to reduce the malaria death toll.
Nature (18 November 2004)
| Full Text |
Europe's stem-cell workers pull together
The European Stem Cell Network held its inaugural meeting in Spain, and brought together scientists from 14 European nations and Israel in a bid to promote collaboration.
Nature (18 November 2004)
| Full Text |
Grade expectations for German research institutes
To help students and researchers separate the wheat from the chaff, Germany's science council has proposed a rating system for the country's publicly funded research institutes.
Nature (18 November 2004)
| Full Text |
WHO calls for vaccine boost to prepare for flu pandemic
Last week, WHO officials met with vaccine makers, public-health experts and government representatives in a bid to speed up the production of flu vaccines to avert a global pandemic.
Nature (18 November 2004)
| Full Text |
Grant-transfer plan paves the way for European mobility
The scientific borders of ten nations have been loosened to allow national grants to be spent in other countries.
Nature (18 November 2004)
| Full Text |
Molecular biology enjoys double celebration
The club of life scientists this week celebrates the fortieth anniversary of its transformation into EMBO, the European Molecular Biology Organization.
Nature (18 November 2004)
| Full Text |
Unanimous vote approves tweak to smallpox genome
An influential committee at the World Health Organization (WHO) has voted in favor of modifying genes in the smallpox virus, and in the vaccine strains that eradicated the disease.
Nature (18 November 2004)
| Full Text |
Britain to combat conflicts of interest in drug regulators
If government proposals are accepted, advisers on the panels that assess drug safety and performance will have to relinquish all financial interests in the pharmaceutical industry.
Nature (18 November 2004)
| Full Text |
Watchdogs call academies to account over conflicts of interest
The National Academy of Sciences has changed the composition of an expert panel following charges of conflict of interest from environmental watchdogs.
Nature (11 November 2004)
| Full Text |
Trust gives warm welcome to open access
The Wellcome Trust endorses public archive for biomedical research as all papers reporting the results of research funded by the trust will in future have to be placed in a central public library.
Nature (11 November 2004)
| Full Text |
Joys match fears as California agrees to stem-cell proposal
A $3-billion programme that intends to make California a world centre for human embryonic stem-cell research got the green light from voters on 2 November, but some fear repercussions.
Nature (11 November 2004)
| Full Text |
Bush set to keep core science team for second term
Elias Zerhouni is likely to remain the director of the National Institutes of Health and Bush appointee Arden Bement is on course to run the National Science Foundation (NSF).
Nature (11 November 2004)
| Full Text |
Herbicide critic dropped from pollution conference
A California biologist is accusing Minnesota officials of censorship for blocking his conference lecture about environmental damage associated with a popular agricultural herbicide.
Nature (11 November 2004)
| Full Text |
Hopes rise for RNA therapy as mouse study hits target
Biologists at the company Alnylam Pharmaceuticals this week publish results showing that RNA interference — RNAi, for short — can lower cholesterol levels in mice.
Nature (11 November 2004)
| Full Text |
Creative Commons ponders share options
A not-for-profit organization is preparing to launch a form of science licensing that it says will give researchers more flexibility when they publish and share data.
Nature (11 November 2004)
| Full Text |
WHO seeks system for tracking global clinical trials
The World Health Organization (WHO) hopes to earn international support next week for a far-reaching plan to set up a global tracking system for clinical trials.
Nature (11 November 2004)
| Full Text |
US NCI launches nanotechnology plan
The US National Cancer Institute (NCI) formally unveiled its Alliance for Nanotechnology in Cancer, a 5-year, $144.3 million initiative to fund the development of nanotechnology-based cancer products.
Nature Biotechnology (November 2004)
| Full Text |
Kenyan dispute illuminates bioprospecting difficulties
The Kenya Wildlife Service (KWS) planned to launch a multi-million dollar legal claim against Genencor and Procter & Gamble, alleging that a microbial cellulase enzyme was illegally obtained from a soda lake in the country.
Nature Biotechnology (November 2004)
| Full Text |
China takes steps to secure pole position in primate research
The low running costs and the lack of protesters puts China in pole position to become a global centre for biomedical research in primates.
Nature (4 November 2004)
| Full Text |
Early embryos fuel hopes for shortcut to stem-cell creation
In an advance that could boost the production of stem cells for medical research, fertility researchers have grown human embryonic stem cells from an embryo that was just four days old.
Nature (4 November 2004)
| Full Text |
Mouse sequencing plan aims to boost models
Efforts to find genes involved in human disease are set to benefit from a plan to sequence the genetic code of 15 different mouse strains.
Nature (4 November 2004)
| Full Text |
Beta-blocker goes on trial as asthma therapy
The US Food and Drug Administration approved the trial on nadolol, as a potential treatment for asthma, despite warnings on its packaging that it should not be prescribed to asthmatics.
Nature (4 November 2004)
| Full Text |
Scientists seeking HIV in all the wrong places
The surpising discovery that HIV annihilates cells in the gut, rather than the blood, may mean vaccines should be refocused.
Nature Medicine (November 2004)
| Full Text |
Spain breaks financial pact with pharmaceutical industry
The Spanish pharmaceutical industry is up in arms against a new law that requires companies to give the government money based on their drug sales.
Nature Medicine (November 2004)
| Full Text |
Scientists stumped by test that promises tailored treatment
New diagnostic tests promise to help doctors predict individual's response to drugs — but only if they can first learn to read the tests.
Nature Medicine (November 2004)
| Full Text |
Database draws attention to not-so-Nobel intentions
A database of more than 4,300 Nobel Prize nomination letters, available on the Karolinska institute's website, in part explains the dominance of male winners in the field of Physiology or Medicine.
Nature Medicine (November 2004)
| Full Text |
Israeli researchers eye simple test for multiple sclerosis
Researchers are set to begin clinical trials of a blood test that can easily distinguish between severe multiple sclerosis (MS) and a benign form of the disease.
Nature Medicine (November 2004)
| Full Text |
Reports of SIDS-virus link greatly exaggerated, experts say
A link between the newly discovered human parechovirus 3 and Sudden Infant Death Syndrome (SIDS) might have been greatly exaggerated.
Nature Medicine (November 2004)
| Full Text |
Chiron flu flap suggests vaccine industry needs shot in the arm
Scientists are calling for changes to vaccine development after the surprise announcement that Chiron will be unable to deliver half the US flu vaccine supply.
Nature Medicine (November 2004)
| Full Text |
Genetics may aggravate India's growing AIDS problem
The genetic makeup of Indians favors a fast and easy spread of AIDS, suggesting that an AIDS vaccine developed elsewhere may not be effective, Indian scientists have cautioned their government.
Nature Medicine (November 2004)
| Full Text |
News in brief
Wisconsin follows California in funding stem-cell research
| Asian biologists seek self-sufficiency in network development
| France to import ES cells
| Brazil's biotech bill
| Industrial biotech goes global
| Flu vaccine shakeup
| Asthma mAb deal
| Latin America records rapid rise in research publications
| Spanish stem-cell law allows IVF embryo use
| Vioxx withdrawal fuels complaints against FDA
| China's new Pasteur Institute to be Asia's largest
| NIH set to ban outside consulting
| UN's largest anti-polio drive a success
News Features
Biogenerics standoff
Healthcare costs are out of control. Generic biotech products could ease the pain. What's holding things up? Stephan Herrera investigates.
Nature Biotechnology (November 2004)
| Full Text |
Stuck on you
Recent studies are pointing the way for new uses of an ancient treatment — leeches. Helen Pilcher wades in to find out how these creatures could help the arthritic.
Nature (4 November 2004)
| Full Text |
Profile: David Ho
Credited with some of the biggest breakthroughs in tackling HIV/AIDS, David Ho has been a star from the beginning. But in a field fraught with controversy, fame may have come at a cost.
Nature Medicine (November 2004)
| Full Text |
|
